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F-actin-rich contractile endothelial pores prevent
vascular leakage during leukocyte diapedesis
through local RhoA signalling
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During immune surveillance and inflammation, leukocytes exit the vasculature through
transient openings in the endothelium without causing plasma leakage. However, the exact
mechanisms behind this intriguing phenomenon are still unknown. Here we report that
maintenance of endothelial barrier integrity during leukocyte diapedesis requires local
endothelial RhoA cycling. Endothelial RhoA depletion in vitro or Rho inhibition in vivo provokes
neutrophil-induced vascular leakage that manifests during the physical movement of
neutrophils through the endothelial layer. Local RhoA activation initiates the formation
of contractile F-actin structures that surround emigrating neutrophils. These structures
that surround neutrophil-induced endothelial pores prevent plasma leakage through
actomyosin-based pore confinement. Mechanistically, we found that the initiation of RhoA
activity involves ICAM-1 and the Rho GEFs Ect2 and LARG. In addition, regulation of
actomyosin-based endothelial pore confinement involves ROCK2b, but not ROCK1. Thus,
endothelial cells assemble RhoA-controlled contractile F-actin structures around endothelial
pores that prevent vascular leakage during leukocyte extravasation.
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T
he clinical signs of inflammation, redness, heat, swelling
and pain are caused by the acute inflammatory
response including increased vasodilatation, enhanced
microvascular permeability and leukocyte recruitment. During
inflammation the endothelial barrier becomes more permissive
for large molecules, leading to local plasma proteins leakage and
oedema formation. Whether leukocyte transendothelial migration
(TEM) directly causes increased microvascular permeability
has been controversial for decades. Certain studies suggested
leukocyte adhesion and transmigration to be the critical events
leading to tissue damage and organ failure during inflammation
and ischemia reperfusion1,2, since neutrophil depletion or
CD11-/CD18-blocking antibodies have been shown to attenuate
vascular injury under these circumstances2–5. However, when
microvascular permeability was measured simultaneously with
leukocyte–endothelial interactions, local plasma leakage sites
were often different from those of leukocyte adhesion or
transmigration6–11. Recently, it has been shown that
intravenous injection of tumour necrosis factor (TNF)-a caused
significant leukocyte adhesion and transmigration but did not
affect basal microvessel permeability12. Moreover, several studies
have shown that the timing of leukocyte adhesion and
transmigration are not well linked with the evoked permeability
change during acute inflammation13–16. Most of the
abovementioned studies are descriptive, molecular evidence for
the uncoupling between leukocyte TEM and vascular
permeability has been recently shown by Wessel and colleagues.
They mechanistically uncoupled leukocyte extravasation and
vascular permeability by showing that opening of endothelial
junctions in those distinct processes are controlled by different
tyrosine residues of VE-cadherin in vivo17. However, how the
endothelium maintains a tight barrier during leukocyte
transendothelial migration is still unknown18.
Here we investigate the mechanism by which endothelial cells
(ECs) prevent vascular leakage during leukocyte TEM. We
examine the correlation between neutrophil extravasation and
the evoked permeability changes during acute inflammation
in vitro and in vivo. Spatiotemporal RhoA activation during
leukocyte crossing is measured using a recently developed RhoA
biosensor19. In addition, we use fluorescently-tagged Lifeact and
Lifeact-EGFP transgenic knock-in mice to investigate endothelial
filamentous (F)-actin dynamics in remodelling junctions during
neutrophil diapedesis in vitro and in vivo, respectively. We show
that endothelial pore restriction limits vascular leakage during
leukocyte extravasation, which is driven by a basolateral
actomyosin-based structure that requires local endothelial RhoA
activation.
Results
RhoA controls vascular leakage during leukocyte diapedesis. To
investigate the molecular mechanism that controls endothelial
barrier function during neutrophil TEM, we simultaneously
measured neutrophil transmigration kinetics and fluorescein iso-
thiocyanate (FITC)–dextran leakage across TNFa-stimulated
human umbilical vein endothelial cells (ECs) towards a C5a gra-
dient, for 60 min. Neutrophil transmigration across control ECs
was associated with minimal FITC–dextran leakage (Fig. 1a).
Increasing neutrophil numbers in the upper compartment up to
10-fold did not induce FITC–dextran leakage, indicating that ECs
maintained their barrier function, despite increased numbers of
transmigrating neutrophils (Supplementary Fig. 1a). To
investigate the functional role of RhoA in EC barrier maintenance
during neutrophil TEM, we depleted RhoA using siRNA
(Supplementary Fig. 1b). We found that endothelial RhoA
depletion increased FITC–dextran leakage during neutrophil
extravasation, whereas minimal FITC–dextran leakage was
measured during neutrophil crossing through control ECs
(Fig. 1a,b). Correlation analysis showed that the increase in FITC–
dextran leakage was highly correlated to neutrophil transmigration
(Fig. 1c). Note that endothelial RhoA depletion did not alter
FITC–dextran leakage under basal conditions, which was com-
parable to control EC (Fig. 1a,b). Moreover, endothelial resistance
measured under physiological flow conditions was significantly
reduced during transmigration of neutrophils across Rho-inhib-
ited endothelium (Supplementary Fig. 1c). We next investigated
the role of RhoA in EC barrier maintenance during neutrophil
TEM in vivo. Vessel permeability was monitored by Tetra-
methylrhodamine (TRITC)–dextran leakage into the cremaster of
C57BL/6 wild type (WT) or LysM–GFP mice during interleukin
(IL)-1b and TNF-a-stimulated neutrophil recruitment. Intras-
crotal administration of anti-PECAM-1 labelling antibody resulted
in a strong labelling of EC junctions in cremasteric venules
(Fig. 1d). Administration of IL-1b and TNF-a enhanced leakage of
intravenous TRITC–dextran into the interstitium and neutrophil
recruitment into the cremaster (Fig. 1d; Supplementary Fig. 1d).
Rho inhibitor I (C3)-treated animals showed similar extravasated
neutrophil levels, however, TRITC–dextran leakage in those ani-
mals was highly increased compared with IL-1b and TNF-a
administration alone (Fig. 1d,e). Although no change in neu-
trophil extravasation was measured in the presence or absence of
C3, we cannot exclude that the inhibitor affects other cells. Neu-
trophil extravasation and TRITC–dextran leakage in WT mice
were not correlated in individual mice, although there was an
overall association between extravasation and permeability,
whereas the two processes in Rho-inhibited animals showed a
highly significant correlation (Fig. 1f). Animals treated with C3
alone showed unaltered basal vascular permeability
(Supplementary Fig. 1e). Thus, neutrophil extravasation and
evoked changes in vascular permeability during inflammation are
not correlated. However, when endothelial RhoA is inhibited,
neutrophil diapedesis provokes vascular leakage, suggesting that
endothelial RhoA is required to maintain a tight EC barrier during
leukocyte diapedesis in vivo.
Spatiotemporal RhoA activation during leukocyte diapedesis.
To examine spatiotemporal RhoA activation in ECs during EC
barrier maintenance associated with neutrophil TEM, we used a
recently developed fluorescence resonance energy transfer
(FRET)-based RhoA biosensors called the Dimerization
Optimized Reporter for Activation (DORA) RhoA sensors
(Fig. 2a)19. DORA RhoA biosensors design were based on the
published RhoA biosensor20. The ON-state FRET efficiency of the
GTPase was improved through modelling of the fluorescent
protein dimers and the GTPase-effector domain complexes.
Stable a-helical repeats from ribosomal protein L9, rather than an
unstructured linker, were inserted between the fluorescent
proteins to disrupt dimerization and diminish FRET efficiency
in the inactive state (Fig. 2a). As a control, DORA RhoA mutant
Protein kinase N (PKN) was developed to report misalignment of
Cerulean3 (Cer3) and Venus image before and after image
registration, motion artefacts or pH changes affecting the sensors
fluorescent proteins. Glutamine substitution for a leucine at
position 59 in the PKN domain prevents PKN binding to
activated RhoA21. The characterizations of both DORA RhoA
biosensors are described in online methods (Supplementary
Figs 2 and 3a). From these validation experiments, we conclude
that the DORA RhoA biosensor accurately reports RhoA
dynamics in ECs downstream from endogenous stimuli such as
thrombin (Fig. 2b; Supplementary Fig. 1f).
To study spatiotemporal RhoA activation in ECs during
neutrophil TEM, we expressed the DORA RhoA biosensor in ECs
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and investigated RhoA activation following neutrophil extravasa-
tion under physiological flow conditions. Important to note,
Venus and Cer3 emission were simultaneously recorded utilizing
a double-camera system, since sequential image acquisition
resulted in motion artefacts induced by migrating leukocytes
displacing fluorescent signals in ECs. We found unaltered RhoA
biosensor activation during neutrophil rolling and crawling over
the endothelium (Fig. 2c,g). Also RhoA activation during the
initial opening of EC junctions was found to be unaltered
(Fig. 2d). However, RhoA biosensor activity in the endothelium
was locally increased at sites were neutrophils breeched the
endothelium, between the first and second minute of neutrophil
diapedesis (Fig. 2d–f, Supplementary Fig. 2d; Supplementary
Movie 1). On the basis of the normalized ratiometric imaging and
the relative displacement of the sensor, the data showed a 1.2-fold



















Neutrophils per 5×104 μm2
0 20 40






















































































































































































































































































































NATURE COMMUNICATIONS | DOI: 10.1038/ncomms10493 ARTICLE
NATURE COMMUNICATIONS | 7:10493 | DOI: 10.1038/ncomms10493 | www.nature.com/naturecommunications 3
has been observed during RhoA activation after thrombin
stimulation (Fig. 2h,i). The negative control DORA RhoA
biosensor (mutant PKN) showed no change in FRET during
leukocyte diapedesis (Supplementary Fig. 3b,c; Supplementary
Movie 2). Importantly, expressing the DORA RhoA biosensors in
ECs did not interfere with neutrophil TEM. Thus, endothelial
RhoA is transiently and locally activated during the final stage of
neutrophil diapedesis, but not during crawling or opening of
endothelial junctions, indicating a role for local RhoA activity in
EC barrier maintenance during the final stage of neutrophil
extravasation.
F-actin-rich endothelial pores during diapedesis. To investigate
endothelial F-actin dynamics during neutrophil diapedesis, we
transfected ECs with GFP- and/or mCherry-tagged Lifeact22. It is
important to note that phalloidin staining to visualize F-actin
cannot be used to investigate endothelial actin structures that are in
close proximity of transmigrating leukocytes, since F-actin in both
leukocytes and ECs are visualized by phalloidin staining, making it
impossible to discriminate between the two (Supplementary
Fig. 3d). Transmigrating neutrophils initiated small endothelial
pores in the endothelial lining. To study those endothelial pores at
high resolution, transmigrating neutrophils were fixed with
formaldehyde when partly breeched the endothelium. Confocal
microscopy imaging and three-dimensional (3D) reconstruction
showed that ECs assembled F-actin-rich structures around
endothelial pores through, which neutrophils transmigrated, both
during transcellular and paracellular migration (Fig. 3a;
Supplementary Movies 3–5). During paracellular migration, the
junctional protein VE-cadherin was distributed to the endothelial
pore margins (Fig. 3a). Interestingly, using ECs expressing either
Lifeact-GFP or Lifeact-mCherry, we found that paracellular pores
were formed by at least two ECs. At the structures apical site,
filopodia-like protrusions were found, whereas at the basolateral
site, a cortical actin ring appeared during leukocyte crossing
(Fig. 3b–d). In contrast to VE-cadherin distributed to the pores
margins, the junctional protein PECAM-1 was localized around
the basolateral F-actin ring and distributed to apical protrusions
surrounding migrating leukocytes during trans-and paracellular
migration. (Supplementary Fig. 3e,f). Moreover, we found that the
adhesion molecule ICAM-1 was localized in the apical protrusions
at endothelial pores (Supplementary Fig. 4a). We found that
B90% of all neutrophils and monocytes used the paracellular
route, whereas B10% migrated transcellular, in line with the
migratory preference for neutrophils and monocytes found
in vivo23 (Fig. 3e). Note that all these diapedesis events by either
neutrophils or monocytes were associated with basolateral F-actin
ring formation around endothelial pores (Fig. 3e). Within the
paracellular route of migration, leukocyte transmigration through a
bi-cellular or a multicellular junction was B50% (Supplementary
Fig. 4b). In conclusion, ECs assemble F-actin-rich ring-like
structures around endothelial pores through which neutrophils
and monocytes transmigrate. This data indicate that maintenance
of EC barrier function during leukocyte diapedesis involves actin
cytoskeleton strengthening around endothelial pores. Basolateral
F-actin ring formation may tighten the endothelial barrier during
neutrophil crossing, making the leukocyte-induced endothelial
pore impermeable for macromolecules.
F-actin-rich endothelial pores are confined in size. Electron
microscopy studies showed that ECs maintain intimate
contact with transmigrating neutrophils during the entire
transmigration process15,24. To examine the dynamic
contact between ECs and extravasating neutrophils, we
examined F-actin-enriched endothelial pore shape and size in
relation to neutrophil size. Real-time recordings of transmigrating
neutrophils through ECs expressing GFP-tagged Lifeact
showed increased F-actin assembly around endothelial pores
(Supplementary Movie 6).
The kinetics of neutrophil diapedesis is on an average 2 min
and can be distinguished into early, mid and late diapedesis based
on endothelial pore size and neutrophil morphology (Fig. 4a–c).
Endothelial pore formation started when neutrophils partly
breeched the endothelium, defined as early diapedesis. Following
neutrophil diapedesis, most endothelial pores are maximal
enlarged 1 min after transmigration was initiated, defined as
mid diapedesis (Fig. 4a–c). Subsequently, the endothelial pore is
closed in conjunction with transmigrating neutrophils until
completely under the endothelium, a stage defined as late
diapedesis (Fig. 4a–c). Real-time imaging of neutrophil diapedesis
under physiological flow conditions showed that neutrophil total
surface area before TEM was roughly 100 mm2, which was
reduced to o20 mm2 to fit the confined gap in the endothelium
that had a maximal inner-surface area of 19 mm2 (Fig. 4b,c). To
investigate the morphology of de novo formed F-actin-positive
rings and F-actin-positive apical protrusions that surround
endothelial pores during neutrophil TEM, we trapped neutrophils
at different stages of diapedesis. Interestingly, de novo formed
F-actin-positive rings surrounding endothelial pores were found
throughout all diapedesis steps, but not during neutrophil
adhesion or crawling steps (Fig. 4d; Supplementary Fig. 4c).
Quantification of endothelial pore size showed significant larger
pores during mid diapedesis than during early and late diapedesis
when pores open and close, respectively (Fig. 4d). We next
Figure 1 | Impaired endothelial RhoA function results in increased vascular leakage during leukocyte diapedesis in vivo. (a) Extravasation kinetics of
calcein-red-labelled neutrophils and FITC–dextran through TNF-a treated ECs cultured on 3-mm pore permeable filtres. Neutrophils transmigrated towards
a C5a chemotactic gradient in the lower compartment. Four conditions were tested; RhoA depletion (EC)þ neutrophils (Orange line), controlþ neutrophils
(purple line), RhoA depletion (EC) only (red line) and control only (green line). (b) Quantification of FITC–dextran and neutrophil extravasation after
20 min of neutrophil transmigration. Immunoblot of RhoA silencing can be found in supplementary fig. 8. (c) Correlation analysis of dextran and neutrophil
extravasation kinetics through control and RhoA-depleted ECs. (d) Confocal intravital microscopy of 20–80mm diameter cremasteric
venulesin LysM–GFP mice (green neutrophils) immunostained in vivo for EC junctions by intrascrotal injections of fluorescent-labelled PECAM-1 (blue) and
stimulated for four hours with IL-1b and TNF-a only, or with Rho-inhibitor (C3). A second dose of Rho inhibitor was given intrascrotally and TRITC–dextran
(40 kDa) was injected intravenously at T¼ 2 h and allowed to circulate until T¼4 h. Scale bar, 100 mm. (e) Neutrophil extravasation in animals
left unstimulated (control), stimulated with C3 alone, IL-1b/TNFa treated, IL-1b/TNFa treatedþC3 or IL-1b/TNFa treatedþ neutrophil depletion.
(f) Correlation analysis of dextran and neutrophil extravasation kinetics in animals stimulated with IL-1b/TNFa alone or with IL-1b/TNFa treatedþC3.
***Po0.001 control versus RhoA-depleted HUVEC (ANOVA) or P¼0.3504 control versus RhoA-depleted HUVEC (Student’s t-test) (b). r¼0.2547
P¼0.359 (Pearson’s correlation) transmigrated neutrophils versus FITC–dextran leakage in control HUVECs or r¼0.6345 **Po0.01 (Pearson correlation)
transmigrated neutrophils versus FITC–dextran leakage in RhoA-depleted HUVECs (c). P¼0.4230 IL-1b/TNFa versus IL-1b/TNFaþC3 (Student’s t-test)
(e). r¼0.8258 **Po0.01 (Pearson’s correlation) transmigrated neutrophils versus FITC–dextran leakage in IL-1b/TNFaþRho inhibitor treated mice (f).
Data are from three experiments (a–c) or are representative of 5 to 13 (d–e) or 9 (f) independent experiments ((d–f) one mouse per experiment; error bars
(a–c,e,f), s.e.m).
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measured, the pore size width, length and height of F-actin-rich
endothelial pores surrounding transmigrating neutrophils and
monocytes. On average, endothelial pores are 4-mm wide, 6-mm
in length and mostly oval shaped for all leukocytes migrating
through the cell–cell junctions (Supplementary Fig. 4d,f). In
addition, we found that only during diapedesis B40% of the
endothelial pores contained F-actin-rich apical protrusions
(Fig. 4d). No such structures were detected during the crawling
step. These structures reached a maximal height of 6–7 mm
(Supplementary Fig. 4e). Transcellular pores were found to be
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more round or circular shaped and had an average circularity of
about 1.3 according to the circularity index (Supplementary
Fig. 4f). Endothelial pore sizes showed remarkably little variation,
despite leukocyte size, type or transmigration route (Fig. 4e).
Thus, endothelial pores induced by extravasating neutrophils and
monocytes are confined in size and close directly behind
transmigrated cells. Active endothelial pore confinement and
pore closure corroborated earlier findings that showed intimate
contact between neutrophils and ECs during the entire TEM
process and provides an explanation for limited transendothelial
escape of macromolecules during neutrophil crossing.
Pore confinement and pore closure requires endothelial RhoA.
Our data showed that increased endothelial RhoA activity during
neutrophil TEM corresponded to endothelial pore restriction and
closure during mid and late diapedesis. To investigate whether
RhoA regulates endothelial pore confinement, we silenced
endothelial RhoA using siRNA. RhoA was successfully depleted
as shown by western blot analysis (Supplementary Fig. 5a).
Confocal microscopy showed that RhoA depletion in ECs
reduced Lifeact-GFP accumulation around endothelial pores,
whereas Lifeact-GFP in the apical protrusions was still present
(Fig. 5a). Basal F-actin rings in RhoA-depleted ECs were sig-
nificantly reduced compared to control conditions (Fig. 5b).
Endothelial RhoA depletion had no effect on the formation of
F-actin-rich apical protrusions (Fig. 5b). Quantification of
endothelial pore size showed that in the absence of RhoA,
endothelial pores were not only larger than endothelial pores
formed in control ECs but also did not close properly (Fig. 5c).
Note that neutrophil adhesion and transmigration under phy-
siological flow conditions were unaltered in RhoA-depleted ECs
(Fig. 5d). To study if VE-cadherin signalling regulates endothelial
pore size, we depleted VE-cadherin and analysed endothelial pore
size. However, VE-cadherin depletion had no effect on
endothelial pore size (Fig. 5e; Supplementary Fig. 5b–d). In
conclusion, RhoA facilitates endothelial pore confinement and
pore closure during leukocyte diapedesis.
Pore confinement is driven by actomyosin contractility. To
investigate how RhoA regulates endothelial pore confinement
during leukocyte diapedesis, we examined RhoA effector myosin
II activation. To study myosin II activation we locally measured
myosin light-chain (MLC) phosphorylation on position Thr18
and Ser19. Immunofluorescent staining of pMLC showed an
asymmetric phosphorylation pattern in F-actin-rich endothelial
pores surrounding transmigrating neutrophils (Fig. 6a). MLC was
particularly phosphorylated at cortical actin bundles as part of the
F-actin ring (Fig. 6a; Supplementary Fig. 5e). Note that the
uropod of the neutrophil is positive for MLC phosphorylation,
most likely to retract its tail during transmigration25. In contrast
to local MLC phosphorylation in control ECs, endothelial pores
in RhoA-deficient ECs were enlarged and negative for local
phospho-MLC (Supplementary Fig. 5e). In addition, we
quantified Lifeact-GFP distribution around endothelial pores
and found asymmetric F-actin distribution around endothelial
pores, indicative of increased tension (Fig. 6b). To corroborate
our findings in vivo, we studied F-actin localization during
leukocyte diapedesis in retinal vasculature of Lifeact-EGFP-
transgenic knock-in mice26. Lifeact-EGFP expression in the
retinas of these mice is largely restricted to the endothelium and
this allowed us to properly visualize F-actin in ECs in situ26,27.
We found that endothelial pores induced by transmigrating
neutrophils (isolectin B4-positive28) were surrounded by Lifeact-
EGFP-positive rings in retinal ECs (Fig. 6c). Quantification of
these rings showed that endothelial pore size in vivo was
comparable to endothelial pores measured in the in vitro set-up
(compare Figs 6d and 4e). Lifeact was present in the basolateral
ring and in apical protrusions that surrounded transmigrating
neutrophils (Supplementary Fig. 5f). These data showed that
apical membrane protrusions in vivo are rich for F-actin and
surround adherent leukocytes. Next, we examined local MLC
phosphorylation in WT mice during IL-1b and TNF-a-induced
neutrophil recruitment in cremasteric venules. PECAM-1 was
used as a marker to visualize endothelial pores in vivo23 (Fig. 6e).
In line with our in vitro findings, endothelial pores in mouse
cremaster venules showed asymmetric MLC phosphorylation
(Fig. 6f,g). To address the role of ROCK in endothelial pore
confinement we depleted the ROCK isoforms ROCK1 and
ROCK2b in endothelial cells and examined vascular
permeability during neutrophil diapedesis. In line with RhoA
inhibition, silencing ROCK 1 and ROCK2b did not prevent the
adhesion or transmigration of neutrophils through the
endothelial monolayer (Supplementary Fig. 6a,b). Basal
endothelial barrier function in ROCK1 or ROCK2b deficient
ECs was not affected. However, neutrophil diapedesis through
ROCK2b, but not ROCK1 deficient ECs elicited increased
endothelial permeability up to a twofold (Supplementary
Fig. 6a,b). These findings may indicate that endothelial pore
confinement is mediated through ROCK2b but not ROCK1.
Altogether, local accumulation of F-actin and MLC
phosphorylation is associated with neutrophil diapedesis
in vitro and in vivo, suggesting that endothelial pore
confinement is driven by local actomyosin contractility.
Figure 2 | Spatiotemporal RhoA activation during neutrophil TEM. Endothelial RhoA is locally and transiently activated during neutrophil extravasation
(a) Schematic illustration of the DORA RhoA sensor design containing Rho effector PKN (red), circular permutated Venus (yellow), structured linker
protein L9 (green), circular permutated Cer3 (blue) and RhoA GTPase (green),left panel. Right panel shows the DORA RhoA mutant PKN biosensor that
was developed as a negative control biosensor, the glutamine was substituted for the leucine at position 59 in the PKN domain. This mutation prevents
binding of PKN to activated RhoA. (b) Time-lapse Venus/Cer3 ratio images of DORA RhoA biosensor simultaneously recorded with an epi-fluorescent
microscope showing spatiotemporal RhoA activation upon thrombin treatment (1 U ml 1) in HUVECs. Filled arrows indicate RhoA activation. Scale bar,
10mm. Calibration bar shows RhoA activation (Red) relative to basal RhoA activity (Blue). (c) Epi-fluorescent live-cell imaging of HUVEC expressing the
DORA RhoA biosensor during neutrophil adhesion under physiological flow conditions (0.8 dyne per cm2). Red open arrows indicate adherent neutrophils.
Scale bar, 10mm. Calibration bar shows RhoA activation (red) relative to basal RhoA activity (blue). (d) Epi-fluorescent live-cell imaging of HUVECs
expressing the DORA RhoA biosensor during neutrophil TEM. Time-lapse images of DIC (upper) Venus/Cer3 ratio images of DORA RhoA biosensor
(middle) and Merge (bottom) during leukocyte diapedesis. Open arrows indicates adherent neutrophil at the apical side of the endothelium. Filled arrows
indicate local RhoA activation during neutrophil diapedesis. Scale bar, 10mm. (e) Detailed zoom of RhoA activation during neutrophil adhesion (open
arrows) prior diapedesis at time point t¼ 00:12 min. (f) Detailed zoom of local RhoA activation during neutrophil transmigration at time point
t¼01:12 min. Filled arrows indicate local RhoA activation during neutrophil diapedesis. Scale bar, 10 mm. (g) Quantification of temporal RhoA activation
during multiple neutrophil transmigration events starting at time zero (arrow). (h) Quantification of temporal RhoA activation during multiple neutrophil
adhesion events starting at time zero (arrow). (i) Quantification of DORA RhoA biosensor activation after thrombin treatment (1 U ml 1) in HUVEC.
Asterisk indicates thrombin addition. Data represent mean and s.e.m of 7 experiments (g) 5 experiments and (h) 10 experiments (i).
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Pore confinement requires ICAM-1, LARG and Ect2. To
investigate the signalling events upstream from RhoA, we focused
on the involvement of guanine-nucleotide exchange factors (GEF)
and performed a GEF screen that included: p115RhoGEF, Ect2
and LARG. Depletion of endothelial LARG together with Ect2
increased endothelial pore size, whereas depletion of LARG, p115
and Ect2 alone was not sufficient (Fig. 7a; Supplementary Fig. 6c).
Quantification of endothelial pore size at different stages of dia-
pedesis showed that endothelial pores in LARG- and Ect2-
depleted endothelium were enlarged during early and mid dia-
pedesis, but had no effect on endothelial pore closure (Fig. 7b).
Under these conditions the number of F-actin-positive rings and
F-actin-positive apical protrusions was unaltered (Fig. 7c).























































































Figure 3 | ECs assemble F-actin-rich ring-like structures around transmigrating leukocytes. (a) Confocal imaging of para- and transcellular migrating
leukocytes through Lifeact-GFP expressing HUVECs. Filled arrows indicate EC F-actin (Lifeact in green) assembly around extravasating leukocytes.
Open arrows indicate VE-cadherin (directly labelled Alexa-647 antibody in red) distribution to the F-actin structure sites during paracellular diapedesis.
Asterisks indicate extravasating leukocyte (DAPI in blue) in DIC. Flow speed 0.8 dyne per cm2. Scale bar, 5 mm. (b) Confocal imaging showing a Z-stack of
Lifeact-GFP and Lifeact-mCherry positive endothelial membrane structures from apical to basal plane. Open arrows indicate filopodia-like protrusions at
the apical site of the structure. Filled arrows indicate the cortical actin ring at the basolateral site that appeared during leukocyte crossing. Asterisk
indicates extravasating leukocyte (DAPI in blue). Scale bar, 5 mm. (c) Cartoon of endothelium during basal-stage and leukocytes diapedesis showing
filopodia-like protrusions and the basolateral F-actin ring. (d) X–Z (10 mm) and Y–Z (10mm) projections of confocal Z-stack shown in Fig. 1b.
(e) Quantification of percentage F-actin-rich endothelial pores associated with neutrophil and monocyte extravasation during para- and transcellular
migration. Statistical significance was tested with ANOVA. Data are representative for three independent experiments (a–e) with 37–65 transmigration
events per group (error bars (e) s.e.m).
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Figure 4 | Endothelial pores formed during para- and transcellular leukocyte transmigration are confined in size. (a) Epi-fluorescent live-cell imaging of
ECs expressing Lifeact-GFP. Red open arrows indicate F-actin-rich endothelial pore formation during leukocyte diapedesis under physiological flow
conditions (0.8 dyne per cm2). Filled arrows indicate extravasating leukocyte in DIC. Dashed lines indicates neutrophil localization under the endothelium.
Scale bar, 10mm. (b,c) Quantification of size changes occurring in the neutrophil cell body and endothelial pore during neutrophil diapedesis. Endothelial
pore size (red), neutrophil cell body apical (blue) and neutrophil cell body under EC (yellow), diapedesis starts at time zero. (d) Quantification of Neutrophil
size, F-actin-positive ring structures, F-actin positive apical protrusions and endothelial pore size. (e) Quantification of endothelial pore size for neutrophils
and monocytes during paracellular migration. ****Po0.0001 (analysis of variance). Data are representative of four independent experiments (d,e) with 40
transmigration events per group. Data in b and c are representative of 10 transmigration events (error bars (b–e) s.e.m).
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showed increased endothelial permeability during neutrophil
diapedesis, whereas basal EC barrier function was not affected
(Fig. 7d; Supplementary Fig. 6d–f). Neutrophil diapedesis through
Ect2- and LARG-deficient ECs was slightly reduced (Fig. 7d;
Supplementary Fig. 6d). To study LARG and Ect2 recruitment to
the intracellular tail of PECAM-1 or ICAM-1 we performed
clustering experiments induced by anti-ICAM-1- or anti-
PECAM-1-coated beads. We found that LARG and Ect2 are
recruited to the intracellular tail of ICAM-1 (Supplementary
Fig. 6g).Whereas PECAM-1 recruited only LARG, but not Ect2 to
its intracellular tail on clustering (Supplementary Fig. 6h). To
investigate whether ICAM-1 or PECAM-1 initiate and coordinate
local RhoA activation and endothelial pore confinement during
neutrophil diapedesis, we depleted ICAM-1 and PECAM-1 in
ECs and examined the extravasation of calcein-red-labelled
neutrophils and FITC–dextran across EC and measured endo-
thelial pore size. We found that neutrophil transmigration
through ICAM-1-deficient ECs compromised the endothelial
barrier (Fig. 7e; Supplementary Fig. 7a–c), whereas PECAM-1
depletion did not alter endothelial pore size or vascular leakage
(Supplementary Fig. 7d–e). ICAM-1 and PECAM-1 depletion
alone had no effect on endothelial permeability (Fig. 7e;
Supplementary Fig. 7d). In agreement with the existing literature,
endothelial ICAM-1 depletion significantly reduced the number
of transmigrated neutrophils (Fig. 7e). Neutrophil diapedesis
through PECAM-1-deficient ECs showed no reduction in trans-
migration numbers (Supplementary Fig. 7d). These data point out
an important role for ICAM-1, Ect2 and LARG signalling in
controlling RhoA-mediated endothelial pore confinement and EC
barrier protection during neutrophil diapedesis.
Discussion
Leukocytes that cross the endothelium induce large endothelial
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Figure 5 | RhoA signalling is required for endothelial pore confinement. (a) Confocal imaging of paracellular migrating neutrophils through Lifeact-GFP
expressing HUVECs after 72-h transfection with control siRNA (upper panel) or RhoA siRNA (lower panel) under physiological flow conditions (0.8 dyne
per cm2). Open arrows and filled arrows indicate filopodia-like protrusions at the apical site and the cortical F-actin ring at the basolateral site of the
endothelial pore, respectively. Asterisk indicates extravasating neutrophil (DAPI in blue). VE-cadherin (red). Scale bar, 5 mm. (b) Quantification of F-actin-
positive ring structures and F-actin-positive apical protrusions in control versus RhoA-depleted ECs. (c) Quantification of endothelial pore size during early,
mid and late diapedesis. (d) Quantification of neutrophil adhesion and diapedesis through TNF-a treated ECs under physiological flow conditions after 72 h
transfection with control siRNA (open bar) or RhoA siRNA (filled bar). (e) Quantification of endothelial pore size in control versus VE-cadherin depleted
HUVECs. ****Po0.0001 (analysis of variance). Data are representative of four independent experiments (a–e) with 412 transmigration events per group
(error bars (c,e) s.e.m).
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Figure 6 | Endothelial pore confinement is driven by actomyosin contractility. (a) Immunofluorescence analyses of MLC phosphorylation during
neutrophil transmigration. Open and filled arrows indicate Lifeact-mCherry (red) and MLC phosphorylation (green) localization, respectively, during
neutrophil transmigration under physiological flow conditions (0.8 dyne per cm2). Asterisk indicates extravasating leukocyte in DIC. Scale bar, 10mm.
(b) Quantification of F-actin distribution in endothelial pores surrounding transmigrating neutrophils and monocytes. Maximum intensity projection of
F-actin in the endothelial pore was used to quantify F-actin distribution surrounding transmigrating leukocytes. Distribution asymmetry is defined by the
ratio of region of interest ROI-1 and ROI-2 corrected for background. Scale bar, 5 mm. (c) Confocal imaging of F-actin dynamics during leukocyte diapedesis
in retina vasculature of Lifeact-EGFP C57BL6 mice. Filled arrows indicate the vasculature of mice retina, highly expressing Lifeact-GFP. Zoom of ROI, open
arrows indicate the Lifeact-EGFP (green)-positive endothelial pore, filled arrows indicate transmigrating neutrophil. Scale bar, 5 mm. (d) Quantification of
endothelial pore size in retina vasculature. (e) Confocal imaging of PECAM-1 in cremasteric venules during TNF-a and IL-1b induced neutrophil recruitment.
Open arrows indicate PECAM-1 positive endothelial pores that surround extravasating neutrophils (filled arrows). Scale bar, 20 mm. (f) IF analyses of MLC
phosphorylation during neutrophil transmigration into the cremaster of C57BL6 mice. Filled and open arrows indicate phospo-MLC and PECAM-1
localization to endothelial pores, respectively. Scale bar, 5 mm. (g) Quantification of pMLC and PECAM-1 localization in endothelial pores. We quantified
MLC phosphorylation defined as distribution asymmetry. The distribution asymmetry uses the intensity of one ROI versus another ROI as indicated in b.
Because MLC may occur at different heights within the pore we used max projection for this analysis. Data are representative of three independent
experiments (a–g) with 412 transmigration events per group (error bars (b,d,g) s.e.m).
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tissue. However, the mechanisms behind this intriguing
phenomenon are unclear. The present study shows how ECs
limit vascular leakage during leukocyte TEM. We found that
RhoA-mediated F-actin rings contribute to endothelial pore
confinement that maintains endothelial barrier integrity
during leukocyte diapedesis. Neutrophil diapedesis through
ICAM-1-, Ect2/LARG- and RhoA-deficient ECs provokes
vascular leakage that was highly correlated with neutrophil
breeching events. Mechanistically, we found that the initiation of
RhoA activity involves ICAM-1 and the Rho GEFs Ect2
and LARG. In addition, we found that the regulation of








































































































































































































































































































































Figure 7 | ICAM-1 regulates endothelial pore confinement through recruitment of the Rho GEFs LARG and Ect2. (a) Quantification of endothelial pore
size in LARG, p115RhoGEF or Ect2 depleted ECs. (b) Quantification of endothelial pore size during early, mid and late diapedesis in control versus
LARGþ Ect2 depleted ECs. (c) Quantification of F-actin-positive ring structures and F-actin-positive apical protrusions in control versus LARGþ Ect2
depleted ECs.(d) Quantification of FITC–dextran and neutrophil extravasation after 20 min of neutrophil transmigration through control and Ect2/LARG
(d) or ICAM-1-deficient ECs (e). (f) Model of endothelial pore formation. Adherent leukocytes destabilizing cell–cell junctions subsequently insert small
pseudopodia between transient openings in the endothelium (leukocyte probing) during early diapedesis. The next step (mid diapedesis) involves local and
transient RhoA activation that mediates endothelial pore confinement through the formation of a de novo basolateral F-actin ring and actomyosin
contractility. Finally, persistent actomyosin contractility closes the endothelial pore behind transmigrating leukocytes. ICAM-1 is involved in the regulation
of endothelial pore confinement through recruitment of the Rho GEFs LARG and Ect2. Basolateral F-actin ring formation and actomyosin contractility
tightens the endothelial barrier during leukocyte diapedesis, making the leukocyte-induced endothelial pore impermeable for macromolecules.
****Po0.0001 (ANOVA) (a–c).**Po0.01 (ANOVA) (b) *Po0.05 (ANOVA) (e,d).*Po0.05 control versus siLARG/shEct2 (d) **Po0.01 control versus
siICAM-1 (e) (Student’s t-test). Data are representative of three independent experiments (a–e) with 412 transmigration events per group (a–c) (error
bars (a–e) s.e.m). ANOVA, analysis of variance.
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ROCK2b, but not ROCK1. Our work identifies a novel
mechanism that maintains endothelial barrier integrity during
leukocyte extravasation, which is driven by a basolateral
actomyosin-based structure that requires spatiotemporal RhoA
cycling (Fig. 7f).
Inflammation-driven leukocyte recruitment and vascular
permeability are separable events7,8,17. In line with these
observations, we discovered that during the TEM process
endothelial RhoA plays a central role in EC barrier
maintenance, but is redundant for leukocyte transmigration. In
agreement with previous reports, blocking RhoA activity or
depleting RhoA in ECs did not perturb adhesion29 or
transmigration30. In contrast to the general concept that RhoA
activation is required for leukocyte adhesion and opening of
endothelial junctions31–35, we found that endothelial RhoA
was locally and transiently activated during the diapedesis
step and not during neutrophil crawling, firm adhesion or
opening of endothelial junctions prior to leukocyte extravasation.
These processes require a separate, RhoA-independent
mechanism that allows leukocyte–EC adhesion or opening of
endothelial junctions. In agreement with our findings, for both
transmigration routes, endothelial pore opening is in part
mediated by mechanical forces that are generated by migrating
leukocytes. Polarized actin polymerization in the leukocyte elicits
pulling and pushing forces that support the movement of
immune cells through the confined endothelial pore36,37.
ICAM-1 is known to mediate leukocyte–EC interactions, and
crosslinking ICAM-1 using ICAM-1-coated beads or ICAM-1
antibodies results in increased RhoA activation suggesting a role
for ICAM-1-mediated RhoA activation in leukocyte
adhesion32,38–41. However, based on the spatiotemporal
activation of RhoA, we suggest that ICAM-1-mediated RhoA
signalling specifically occurs during the diapedesis step, in
agreement with our data that shows ICAM-1 enrichment only
at diapedesis sites. PECAM-1 was also detected at sites of
diapedesis, for either paracellular or transcellular migration.
Recently, mechanical tension exerted on ICAM-1 and also
PECAM-1 enhanced RhoA activation and MLC
phosphorylation in ECs that was dependent on the recruitment
of the RhoGEF LARG and ICAM-1 clustering41,42. Our work
shows that ICAM-1 clustering indeed promotes the recruitment
of LARG and we additionally found Ect2 to be recruited on
ICAM-1 clustering. Depletion of ICAM-1- and Ect2/LARG in
ECs compromised the endothelial barrier during neutrophil
diapedesis. Indicating that the ICAM-1-LARG/Ect2 signalling
axis is likely to be activated upstream from RhoA activation, to
regulate de novo F-actin rearrangements, endothelial confinement
and barrier protection during neutrophil crossing. Altogether
these data suggest that leukocytes exert mechanical forces on
endothelial adhesion molecules that modulate endothelial F-actin
cytoskeleton through mechanotransduction that may cause
endothelial confinement.
The relationship between Ect2 and actomyosin contractility has
been clearly established by several studies. For instance, Ect2 has
been described to be involved in RhoA activation and contractile
ring formation during cytokinesis43. In addition, it has been
shown that the molecular pathways that regulates local RhoA
activation during cytokinesis are also used to control RhoA
dynamics at the zonula adherens in interphase cells44. Although
no proof for a role of Ect2 in endothelial junction regulation has
been described we can speculate that Ect2 mediates similar
functions in ECs, regulating actomyosin contractility around the
pore. The latter is probable, since depletion of LARG and Ect2
simultaneously results in larger pores without affecting the
number of F-actin rings. In agreement with this hypothesis
overall endothelial pore size in RhoA-deficient endothelial cells
was increased due to the lack of basal F-actin ring formation. In
addition, we observed that RhoA-deficient endothelial cells were
unable to phosphorylate MLC near endothelial pores.
Surprisingly, the length-to-width aspect ratio between
paracellular and transcellular pores was found to be different;
however, this was not due a difference in nuclear size, shape or
composition between neutrophils and monocytes. We speculate
that in case of paracellular migration the amount of VE-cadherin
disassembly at the pores margins may regulate pore size, which
may affect the length/width ratio or circularity. In case of
transcellular migration mechanical forces from the endothelium
might counteract leukocyte-induced forces from all directions
forcing a circular passageway. A physical explanation for circular
transcellular passages may also explained by cellular dewetting45.
Despite different length-to-width ratio of the pores, the overall
pore size is constant independent of leukocyte type, or
transmigration route. This may indicate that the contractile
forces generated during endothelial pore formation are high
enough to counteract the mechanical forces generated by
transmigrating leukocytes. Alternatively, the RhoA-induced
basolateral F-actin ring itself may also add as a limiting factor
for pore confinement on top of the actomyosin-based
contractility. Endothelial pore confinement is probably not
restricted to neutrophil and monocyte diapedesis but may also
occur during the diapedesis of other immune cells such as
T-lymphocytes. Additional research is required to investigate this
hypothesis. Surprisingly, we found that VE-cadherin depletion
did not affect endothelial pore integrity, despite the prominent
VE-cadherin localization at the pores margins. It is known that
other junctional molecules such as N-cadherin may take over the
function of VE-cadherin when VE-cadherin is depleted46. The
fact that we see unaltered pore morphology in VE-cadherin
deficient cells makes it conceivable that other molecules like
N-cadherin take over the function of VE-cadherin controlling the
integrity of the endothelial pore at its margins. It is evident that
VE-cadherin plays a dominant role in endothelial barrier
formation and regulation of leukocyte traffic through the
endothelial barrier. For instance, locking VE-cadherin junctions
reduces the number emigrating leukocytes47 and the
phosphorylation of VE-cadherin at Y731 induced by adherent
leukocytes prior diapedesis is a necessity for junctional
destabilization and paracellular diapedesis17. We cannot exclude
a supportive role for VE-cadherin in endothelial pore integrity,
but we can exclude a direct role for VE-cadherin as a signalling
molecule being involved in controlling and coordinating of
endothelial pore confinement. Whether other junctional proteins
such as JAM-A or CD99, that act distally from ICAM-1, and
signal to RhoA to prevent leakage is currently unknown23,48. We
found that many F-actin rings comprise apical membrane
protrusions. These projections, also known as ‘docking
structures’ or ‘transmigratory cups’, have been suggested to
anchor endothelial adhesion receptors and therefore control
leukocyte adhesion30,39,49–52. However, the biological function of
these structures is still under debate. Interestingly, we found
F-actin rings associated with leukocyte diapedesis that contained
no apical protrusions suggesting that directional neutrophil
diapedesis can occur through other mechanisms than ‘apical
projection’-guidance for instance transendothelial migration-
promoting endothelial chemokines that are locally released
within the endothelial pore53. In agreement with studies
showing that apical projection assembly requires RhoG and
Rac1 but not RhoA activity39,54, we still observed apical
membrane protrusions around migrating leukocytes upon
RhoA depletion, whereas the F-actin rings were significantly
decreased. Suggesting that the basolateral F-actin ring and not the
apical protrusions in the endothelial pore contribute to vascular
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leakage prevention during TEM. Interestingly, in drosophila,
similar actomyosin networks have been found to rapidly close
multicellular wounds by actomyosin contraction55. Studies that
investigated the mechanisms by which ECs repair gaps in the
endothelial monolayer, show that mechanical induced
microwounds in the endothelium are healed by ventral
lamellipodia, a mechanism that may also be involved in the
closure of leukocyte-induced endothelial pores56. Our data show
that RhoA-mediated contractile force generation responsible for
endothelial pore restriction precedes ventral lamellipodia
formation. Moreover, RhoA-mediated pore constriction in ECs
seems to be specific for the closure of leukocyte-induced
endothelial pores, whereas ventral lamellipodia are also
observed in maintenance of basal junctional integrity57. On the
basis of electron microscopy studies, it has been suggested that
the intimate contact between neutrophils and ECs during the
entire transendothelial migration process limits leakage of plasma
proteins. Moreover, several studies showed that ECs reseal the
endothelial barrier before or in conjunction with neutrophils
penetrating the basal lamina15,58. In agreement with these
ultrastructural studies we found that endothelial pores closed
before or in conjunction with neutrophils that fully breeched the
endothelial lining. In the context of EC barrier maintenance it is
well conceivable that endothelial pore confinement and closure
directly prevents vascular leakage during leukocyte diapedesis
whereas ventral lamellipodia restore junctional homeostasis after
leukocyte crossing. Endothelial LSP1 has been implicated in a role
for ‘dome’ formation and controlling permeability during TEM58
and has been found to be activated downstream from ICAM-1
clustering59. Altogether, this may open up the possibility that
ICAM-1 clustering activates RhoA through LSP1. However,
future experiments should show if this signalling axis indeed is
operational during TEM.
In conclusion, we have discovered that local RhoA-mediated
F-actin rings in the endothelial lining prevent vascular leakage
during leukocyte diapedesis. Elucidating the molecular and
cellular mechanisms of barrier maintenance during leukocyte
diapedesis may have implications for the development of new
therapies to restore normal homeostatic junctional remodelling to
counteract vascular dysfunction during chronic inflammation.
Methods
DNA and RNA constructs. The DORA RhoA and DORA RhoA mutant PKN
biosensors were a very kind gift of Yi Wu (University of Connecticut Health centre,
Farmington, USA). Briefly, circular permutated PKN effector of RhoA coupled to
dimeric circular permutated Venus is linked via a ribosomal protein-based linker
(L9H) with dimeric Cerulean3 (Cer3) coupled to RhoA. The DORA RhoA
sequence within a pTriEx-HisMyc backbone is cpPKN(S69-H97-GSG-S14-R68)-
KpnI-GS-dcpVen-L9Hx3-BamHI-dCer3(G229)-NheI-RhoA-WT-HindIII. The
DORA RhoA mutant PKN sequence within a pTriEx-HisMyc backbone is cpPKN
(S69-H97-GSG-S14-R68, L59Q)-KpnI-GS-dcpVen-L9Hx3-BamHI-dCer3(G229)-
NheI-RhoA-WT-HindIII. The Leucine (L) on position 59 in the PKN domain of
the RhoA control biosensor is substituted for a glutamine (Q). The H1R, p63-RFP
and mRFP-RhoGDI-a (pcDNA 3.1) were a kind gift of Joachim Goedhart
(Swammerdam Institute for Life Sciences, University of Amsterdam, Amsterdam,
the Netherlands). pLenti-Lifeact-mCherry, pLenti-Lifeact-GFP, were a kind gift of
Stephan Huveneers (Sanquin, Amsterdam, the Netherlands). shRNA in pLKO.1
targeting VE-cadherin (12) B6 (TRCN 54090), GEF-H1 (TRCN 3174), GEF-H1
(TRCN 3175), p115RhoGEF (TRCN 33567), and Ect2 (TRCN 47686) were
purchased from Sigma Aldrich mission library. siRNA targeting RhoA (sc-29471)
(working concentration 50 nM), ICAM-1 sc-29354 (50 nM), PECAM-1 sc-29445
(50 nM), LARG sc-41800 (50 nM), Rock-1 (sc-29473) (50 nM), Rock-2b (sc-29474)
(50 nM),and scrambled non-silencing siRNA were purchased from (Santa Cruz
Biotechnology, Santa Cruz, CA).
Antibodies. Rabbit antibody against GEF-H1 (55B6) (Cat #4076) (1:1000 for WB),
phosphor-Myosin light-chain Thr18/Ser19 (Cat #3674) (1:100 for IF),
p115RhoGEF (D25D2) (Cat #3669) (1:1,000 for WB), RhoA (67B9) (Cat #2117X)
(1:1,000 for WB) and CD31 (PECAM-1) (89C2) (Cat #3528) (1:1000 for WB) were
purchased from Cell Signaling (BIOKE). Polyclonal rabbit antibody against Ect2
(Cat# 07-1364) (1:1,000 for WB) was purchased from Millipore. Polyclonal goat
antibody against LARG (Cat#AF4737) (1:1,000 for WB) was purchased from R&D
systems. Alexa Fluor 405 Phalloidin (1:100 for IF) was purchased from Promokine
(Cat# PK-PF405-7-01). Polyclonal goat antibody against VE-cadherin (C-19)
(Cat# SC-6458) (1:1,000 for WB), Rock-2 (C-20) sc-1851 (1:1,000 for WB), Rock-1
(H-85) sc-5560 (1:1,000 for WB) were purchased from Santa Cruz (Bio-Connect).
Polyclonal rabbit antibody against ICAM-1 (Cat #SC-7891) (1:1,000 for WB) was
purchased from Santa Cruz Biotechnology. Monoclonal mouse antibody against
Filamin A (Cat #MCA464S) (1:1,000 for WB) was purchased from Serotec.
Monoclonal mouse Alexa Fluor 647 VE-cadherin (55-7H1) ( Cat# 560411)
(1:100 for IF) and Alexa Fluor 488 PECAM-1 (Cat# 555445) (1:100 for IF) were
purchased from Becton Dickinson. Monoclonal mouse antibody against Actin
(AC-40) (Cat# A3853) (1:1,000 for WB) was purchased from Sigma. The Alexa
Fluor 405 goat anti-rabbit IgG (Cat# A31556) (1:100 for IF), Alexa Fluor 647
chicken anti-goat IgG (Cat# A21469) (1:100 for IF), Alexa Fluor 488 chicken
anti-rabbit IgG (Cat# A21441) (1:100 for IF) and Texas red 568 Phalloidin
(Cat #T7471) (1:100 for IF) were purchased from Invitrogen. Secondary
HRP-conjugated goat anti-mouse, swine anti-rabbit antibodies (1:3,000 for WB)
were purchased from Dako (Heverlee, Belgium). Hoechst 33342 (H-1399) (1:50 for
IF) was purchased from Molecular probes (Life Technologies). All antibodies were
used according to manufacturer’s protocol.
Cell cultures and treatments. Pooled human umbilical vein ECs (HUVECs)
purchased from Lonza (P938, Cat # C2519A), were cultured on fibronectin
(FN)-coated dishes in EGM-2 medium, supplemented with singlequots (Lonza,
Verviers, Belgium) HUVECs were cultured until passage 9. HEK-293T were
maintained in DMEM (Invitrogen, Breda, The Netherlands) containing 10% (v/v)
heat-inactivated fetal calf serum (Invitrogen, Breda, The Netherlands),
300 mg ml 1 L-glutamine, 100 U ml 1 penicillin and streptomycin and 1
sodium pyruvate (Invitrogen, Breda, The Netherlands). HeLa cells (American
Tissue Culture Collection: Manassas, VA, USA) were cultured using DMEM
supplied with Glutamax, 10% fetal bovine serum, Penicillin (100 U ml 1) and
Streptomycin (100 mg ml 1). Cells were cultured at 37 C and 5% CO2. HUVECs
were treated with 1 U ml 1 thrombin (Sigma-Aldrich, St Louis, USA) for periods
as indicated, pretreated with 10 ng/ml recombinant TNF-a (PeproTech, Rocky Hill,
NJ) 24 h before each leukocyte TEM experiment, For Rho inhibition cells were
preincubated with cell-permeable Rho inhibitor I (C3) (Cytoskeleton, Cat# CT04)
for 3 h. Cells were transfected with the expression vectors according to the
manufacturer’s protocol with Trans IT-LT1 (Myrus, Madison, WI, USA). Lentiviral
constructs were packaged into lentivirus in Human embryonic kidney (HEK)-293T
cells by means of third generation lentiviral packaging plasmids (Dull et al., 1998;
Hope et al. 1990). Lentivirus containing supernatant was collected on day 2 and 3
after transfection. Lentivirus was concentrated by Lenti-X concentrator (Clontech,
Cat# 631232). Transduced target cells were used for assays after 72 h. Cells were
transfected with siRNA according to manufacturer’s protocol using INTERFERin
(Polyplus). HeLa cell were transfected with Lipofectamine and imaged the next day.
HeLa cells were treated with 100mM histamine (Sigma-Aldrich, St Louis, USA) and
10 mM Pyrilamine (mepyramine; Sigma-Aldrich, St Louis, USA) for periods as
indicated.
Neutrophil and monocyte isolation. Polymorphonuclear neutrophils and
monocytes were isolated from whole-blood derived from healthy donors who
signed an informed consent under the rules and legislation in place within the
Netherlands and maintained by the Sanquin Medical Ethical Committee. The rules
and legislations are based on the Declaration of Helsinki (informed consent for
participation of human subjects in medical and scientific research) and guidelines
for Good Clinical Practice. Whole blood was diluted (1:1) with 5% (v/v) TNC in
PBS. Diluted whole blood was pipetted carefully on 12.5 ml Percoll (room
temperature) 1.076 g ml 1. Tubes were centrifuged (Rotanta 96R) at 2,000 r.p.m.,
slow start, low brake for 20 min. Ring fraction containing lymphocytes and
monocytes was collected and further processed as indicated below*. After
erythrocyte lysis in an ice-cold isotonic lysis buffer (155 mM NH4CL, 10 mM
KHCO3, 0.1 mM EDTA, pH7.4 in Milli-Q(Millipore), neutrophils were centrifuged
at 1,500 r.p.m. for five minutes at 4 C, incubated once with lysis buffer for 5 min
on ice, centrifuged again at 1,500 r.p.m. for 5 min at 4 C, washed once with PBS,
centrifuged again at 1,500 r.p.m. for 5 min at 4 C and resuspended in HEPES
medium (20 mM HEPES, 132 mM NaCl, 6 mM KCL, 1 mM CaCL2, 1 mM MgSO4,
1.2 mM K2HPO4, 5 mM glucose (all from Sigma-Aldrich), and 0.4 % (w/v) human
serum albumin (Sanquin Reagents), pH7.4) and kept at room temperature for not
longer than 4 h until use. *Ring fraction was washed three times with MACS buffer
(0.5% (v/v) bovine serum albumin (BSA) in PBS, 2 mM EDTA in PBS). Ring
fraction was centrifuged at 1,700 r.p.m. for 7 min at 4 C and low break, and
resuspended in 100ml MACS buffer and incubated with 5 ml CD14 microbeads
(Miltenyi biotec, # 130-050-201) for 30 min at 4 C and subsequently washed with
5 ml MACS buffer, centrifuged and resuspended in 1 ml MACS buffer. LS columns
(Miltenyi biotec, # 130-042-401) were placed in QuadroMACS separator (Miltenyi
biotec, # 130-090-976) and cells were subsequently washed three times with 1 ml
MACS buffer. Column was removed from the QuadroMACS separator and
monocytes were collected in a collection tube. Neutrophil and monocyte counts
were determined by cell counter (Casey).
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FITC–dextran permeability assay. ECs (n¼ 200,000) were cultured in FN-treated
24-well cell culture inserts (Corning FluoroBlok, Falcon, 3.0-mm pore size #
351151) and treated with TNF-a overnight. 30 mg FITC–dextran (70 kDa; Sigma) in
HEPES medium (20 mM HEPES, 132 mM NaCl, 6 mM KCL, 1 mM CaCL2, 1 mM
MgSO4, 1.2 mM K2HPO4, 5 mM glucose (all from Sigma-Aldrich), and 0.4 % (w/v)
human serum albumin (Sanquin Reagents), pH7.4) was added to the upper and
0.1 nM C5a (Sigma C-5788) in HEPES medium was added to the lower
compartment. FITC–dextran and calcein red–orange (Molecular probes C34851)
labelled neutrophil (200,000 cells) extravasation was monitored simultaneously for
a period of 60 min with an interval of 1 min by an Infinite F200 pro plate reader
(TECAN) at 37 C. EX BP 485/9 and EM BP 535/20 was used to measure
FITC–dextran kinetics. EX BP 535/9 and EM BP 595/20 was used to measure
neutrophil (calcein red–orange) transmigration kinetics.
Neutrophil and monocyte TEM under physiological flow. HUVECs were
cultured to 70% confluence in FN-coated 6-well plate, and transfected with
different expression vectors (for example, DORA RhoA biosensor) according to the
manufacturer’s protocol with Trans IT-LT1 (Myrus, Madison, WI, USA) for 24 h
or transduced with expression vectors in lentivirus (for example, pLenti-Lifeact-
mCherry) for 72 h. HUVECs were cultured in a FN-coated ibidi m-slide VI0.4 (ibidi,
Munich, Germany) the day before the experiment was executed and stimulated
overnight with TNFa (10 ng ml 1). Freshly isolated neutrophils and monocytes
were resuspended at 1 106 cells per ml in HEPES medium and were incubated for
30 min at 37 C. Cultured HUVECs in ibidi flow chambers were connected to a
perfusion system and exposed to 0.5 ml min 1 HEPES shear flow for 10 min
(0.8 dyne per cm2). Actual levels of injected neutrophils ranged between 0.5 and
2 106 dependent on the donor and activity of the neutrophils. Actual levels of
monocytes ranged between 1.5 and 2.2 106. Neutrophils or monocytes
were subsequently injected into the perfusion system and real-time leukocyte–
endothelial interactions were recorded for 20 min by a Zeiss Observer Z1
microscope using a 40 numerical aperture (NA) 1.3 oil immersion objective or
samples were fixed for immunofluorescent staining and subsequent analysis. All
live imaging was performed at 37 C in the presence of 5% CO2. Transmigrated
neutrophils were distinguished from those adhering to the apical surface of the
endothelium by their transition from bright to phase-dark morphology. Percentage
adherent or transmigrated neutrophils were manually quantified using the ImageJ
plug-in Cell Counter (type 1, adherent cells, type 2, transmigrated cells).
Confocal laser scanning microscopy. Cells were cultured in FN-coated ibidi
m-slide VI0.4 (ibidi, Germany) and transfected or stimulated as indicated. After
treatment, cells were washed with cold PBS, containing 1 mM CaCl2 and 0.5 mM
MgCl2, and fixed in 4% (v/v) formaldehyde for 10 min. After fixation, cells were
permeabilized in PBS supplemented with 0.5% (v/v) Triton X-100 for 10 min
followed by a blocking step in PBS supplemented with 2.5% (w/v) BSA. Cells were
incubated with primary and secondary antibodies and after each step washed with
PBS. Z-stack image acquisition was performed on a confocal laser scanning
microscope (LSM510/Meta; Carl Zeiss Micro-Imaging) using a voxel size of
0.06 0.06 0.48 mm and a 63 NA 1.4 oil immersion objective. Following
acquisition, the sequences of Z-stack images were analysed off-line using
Imaris, which renders the optical sections into 3D models enabling analysis of
leukocyte–endothelial interaction dynamics.
Quantification endothelial pore structures. Real-time endothelial pore dynamics
in HUVECs expressing Lifeact-GFP was analysed by ImageJ. Three parameters
were scored; the area of the neutrophil cell body (luminal site), the area of the pore,
and the area of the neutrophil cell body under the endothelium (abluminal site).
The area (mm2) of each parameter was measured manually by drawing a region of
interest (ROI) resembling the parameter (for example, pore size) and measured in
ImageJ using analyse measure. Endothelial pore sizes of fixed HUVECs were
measured by drawing a ROI resembling various parameters (width, length, height,
circularity and pore size). Length of the endothelial pore was defined as the total
distance of the pore parallel to the junction and width was defined as the total
distance perpendicular to the junction. Circularity of the pore is defined by the
length over width ratio. Pore size was defined as the total surface area of endothelial
pore. Total F-actin in the pore (sum intensity Z-slices) was divided in two equal
ROI. Distribution asymmetry was defined by ROI (1)-BG over ROI (2)-BG ratio.
Leukocytes migrating through the EC body not interrupting junctional
VE-cadherin were scored as transcellular migration, whereas leukocyte migrating
between ECs interrupting junctional VE-cadherin were scored as paracellular
migration.
Characterization of DORA RhoA biosensor. The design of the DORA RhoA
sensor is based on the published RhoA biosensor20. Importantly, the GTPase is
placed at the C terminus of the construct enabling the DORA RhoA biosensor to
localize at the plasma membrane similar to endogenous RhoA (Fig. 2a). FRET
efficiency of the ON-state of the GTPase is improved through modelling of the
fluorescent protein dimers and the GTPase-effector domain complexes. Repeats of
stable a-helix from ribosomal protein L9, rather than an unstructured linker, is
inserted between the fluorescent proteins to disrupt dimerization and diminish
FRET efficiency in the inactive state (Fig. 2a). In ECs, the DORA RhoA sensor
accurately reported thrombin induced RhoA activation, showing a fast and
transient RhoA activation (Fig. 2b, Supplementary Fig. 1f, Supplementary
Movie 7). Quantification of 10 independent experiments showed reproducible
RhoA activation patterns on thrombin treatment (Supplementary Fig. 1f). As a
control, DORA RhoA mutant PKN was generated to report misalignment of Cer3
and Venus image before and after image registration, motion artefacts or pH
changes affecting the sensors fluorescent proteins. The substitution of glutamine
for the leucine at position 59 in PKN prevents the binding of PKN to activated
RhoA, in the DORA RhoA mutant PKN21. The DORA RhoA mutant PKN showed
no change in Venus/Cer3 ratio after thrombin stimulation (Supplementary Fig. 2a;
Supplementary Movie 8). Quantification of 10 independent experiments showed
no change in Venus/Cer3 ratio after thrombin addition in ECs that expressed the
DORA RhoA mutant PKN biosensor (Supplementary Fig. 2a). In addition, Hela
cells that overexpressed the histamine receptor, histamine stimulation induced a
fast and sustained RhoA activation (Supplementary Fig. 2b; Supplementary Movie
9). Subsequent addition of Pyrilamine reduced RhoA activity to baseline levels,
showing that the sensor dynamically reports RhoA activation and inactivation60.
The DORA RhoA mutant PKN showed no change in Venus/Cer3 ratio after
histamine stimulation (Supplementary Fig. 2c; Supplementary Movie 10). To show
that the sensor is cycling between an active and inactive, Rho-GDI-bound form, we
co-expressed Rho-GDI and found a reduced FRET ratio, illustrative for binding to
Rho-GDI (Supplementary Fig. 3a). In conclusion, the DORA RhoA biosensor
accurately reports RhoA dynamics in ECs. Important to note, Venus and Cer3
emission were simultaneously recorded utilizing a double-camera system, since
sequential image acquisition results in motion artefacts induced by migrating
leukocytes displacing fluorescent signals in the ECs.
Characterization of DORA FRET RhoA-sensor. The intrinsic single-chain nature
of the DORA RhoA biosensor rules out the possibility of unequal Cer3 and Venus
localization within the EC. Therefore, DORA RhoA sensor translocation always
results in a paired translocation of Cer3 and Venus emission. In case the biosensor
does translocate (for example, in response to EC shape alterations induced by
migrating neutrophils lowering the local Venus and Cer3 emission dramatically)
sequential imaging may result in erroneous measurements. The delay in the
acquired Cer3 and Venus emission image of around 400–800 ms may therefore
contain an intrinsic local CFP-YFP pixel shift that cannot be solved by registration
software. Therefore, quality of the obtained Venus/Cer3 Ratio acquired by
sequential image acquisition is dependent on the transmigration speed of the
neutrophil. To control for erroneous measurements during sequential image
acquisition one could change the acquisition order of sequential image acquisition
from Cer3-Venus to Venus-Cer3, the DORA RhoA activity status will change from
high- to a low-activity pattern. If the activity pattern alters, then it indicates that an
intrinsic local CFP-YFP pixel shift is present in the sequentially acquired Cer3 and
Venus dataset. To circumvent motion artefacts a dual-camera set-up was used to
acquire Cer3 and Venus emission images simultaneously. In our set-up, photo-
bleaching-rates of Cer3 and Venus are more or less equivalent. Photobleaching
(average±s.d.) was determined by the reduction in fluorescence (1-F/F0) in living
cells after 30 min illumination with HXP V at 20%, 800 ms illumination with an
interval of 5 s. dCer3 photo bleaching was 16.3%±7.6%) and dcpVenus bleaching
was 13.3%±7.9%). All ratiometric images and normalized intensity graphs were
not corrected for photo bleaching, since photobleaching kinetics may change when
FRET changes. Cer3 bleed through into the Venus channel is 57%. All normalized
intensity graphs were corrected for bleed through using the equation (YFP-BG)-
(0.57*(CFP-BG).
DORA FRET RhoA-sensor analysis. We use a Zeiss Observer Z1 microscope with
40 NA 1.3 oil immersion objective, a HXP 120-V excitation light source, a
Chroma 510 DCSP dichroic splitter, and two Hamamatsu ORCA-R2 digital CCD
cameras (2 2 binning) for simultaneous monitoring of Cer3 and Venus
emissions. Image acquisition was performed using Zeiss Zen 2011 microscope
software. The lowest achievable HXP excitation power, through a FRET filter cube
(Exciter ET 436/20 , and 455 DCLP dichroic mirror (Chroma), the emission filtre
is removed) was used to excite the Cer3 donor. The emission is directed to the left
side port by a 100% mirror, to an attached dual-camera adaptor (Zeiss) controlling
a 510 DCSP dichroic mirror. Emission wavelengths between 455 and 510 nm are
directed to an emission filter (ET 480/40, Chroma) and then captured by the
‘straight’ Hamamatsu ORCA-R2 camera resulting in Cer3 image acquisition. The
Emission wavelength 510 nm and higher are directed to a six positions LEP filter
wheel (Ludl Electronic Products) placed in front of the second ‘rear’ Hamamatsu
ORCA-R2 camera. Position 1 in the emission filter wheel is equipped with an ET
540/40 m used for venus image acquisition. Position 2 is left empty to allow
mCherry image acquisition (EX BP 572/25, BS FT 590, EM BP 629/62, Zeiss).
The LEP filter wheel is controlled by the MAC 6000 controller system (Ludl
Electronic Products). Exposure time of DIC image was set to 76 ms and exposure
time of simultaneous CFP and YFP acquisition was set to ±800 ms, images were
subsequently recorded every 5 s for periods as indicated. Offline ratio analysis
between Cer3 and Venus images was done utilizing the MBF ImageJ collection
(Tony Collins). Individual images in the raw Cer3 and Venus image stacks were
background (BG)-corrected using the plug-in ‘ROI, BG subtraction from ROI’. An
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ROI in the image were no cells were present was selected as the background. Next,
the Cer3 and Venus stacks were aligned using the registration plug-in ‘Registration,
MultiStackReg’. A smooth filtre was applied to both image stacks to improve image
quality by reducing the noise. The smooth filtre (mean filtre) was applied over the
entire image and replaces each pixel with the average of its 3 3 neighbourhood.
Next, both image stacks were converted to a 32-bit image format, required for
subsequent masking. A user defined threshold was applied exclusively to the Venus
image stack, converting the background pixels to ‘not a number’ (NaN). It allows
elimination of artifacts in ratio image stemming from the background noise. Finally
the Venus/Cer3 ratio was calculated using the plug-in ‘Ratio Plus’, and a custom
lookup table was applied to generate a colour-coded image illustrating the high
‘red’ and low ‘blue’ activities. Note that some of the plug-ins, namely Multi-
StackReg, and Ratio Plus are not included in the basic MBF ImageJ collection and
should be downloaded from the plug-in page in the ImageJ website
(http://rsb.info.nih.gov/ij/plugins/index.html). Normalized intensity graphs; the
intensity of an manually selected ROI of interest and the BG of the raw Cer3 and
Venus image stacks were measured using the plug-in ROI, Multi Measure in
ImageJ. The raw Cer3 and Venus intensities were BG subtracted using equation
Cer3¼ (Cer3 rawBG), subsequently Venus only was corrected for bleed through
using the equation VenusC¼ (Venus) (0.5748*(Cer3). Normalization of the
individual intensity traces was done by dividing the data by the average over
acquisition 3 to 13. The Venus/Cer3 ratio was calculated from the normalized data
using Excel.
Confocal intravital microscopy of mouse cremaster muscles. To investigate
local myosin light-chain phosphorylation during leukocyte diapedesis, whole-
mounted cremaster muscles of mice expressing endogenously labelled GFP-leu-
kocytes (Lys-EGFP-ki, CX3CR1-EGFP-ki, Tie-2Cre) or C57BL6 mice were fixed,
immunostained and analysed by confocal microscopy. Inflammation in mouse
cremaster muscles was induced by intrascrotal injection (i.s.) of IL-1b/TNF-a
(50 ng IL-1b, 300 ng TNF-a in 400ml saline) or saline (400 ml) for 2 h. EC junctions
were labelled through co-administration of Alexa Fluor-555 or 647-labelled anti-
PECAM-1 mAb (clone 390; 3 mg i.s.). Anti-PECAM mAb clone 390 was conjugated
to Alexa Fluor-555 using a commercially available kit (Invitrogen, Paisley, UK).
The cremasters were surgically exteriorized and TEM was analysed by intravital
microscopy. Straight post-capillary venules of 20–40 mm in diameter were selected
for analysis of leukocyte-vessel wall interactions. Z-stacks of images were captured
by confocal microscopy as described23. The tissues were fixed with 4%
paraformaldehyde for 30 min at a time point with several paracellular pores visible
in the PECAM-1 labelling. Subsequently, tissues were permeabilized with 0.5%
Triton and blocked with 10% BSA and 10 mg ml 1 FC block for 2 h. Tissues were
incubated with anti-phospho Myosin light-chain Thr18/Ser19 (Cat #3674)
purchased from Cell signaling (BIOKE) antibody for 2 days and a further 2 days
with the secondary antibody or IgG isotype control (1:100). Transmigration
induced permeability was examined by looking at fluorescent TRITC–dextran
leakage into the cremaster of C57BL/6 WT or LysM–GFP mice during IL-1b and
TNFa stimulated neutrophil recruitment. Four different groups were defined;
unstimulated, Rho inhibitor I (C3) alone, IL-1b/TNF-a treated, IL-1b/TNF-a
treatedþC3. IL-1b (50 ng), TNF-a (300 ng), Rho-inhibitor (1 mg) and anti-
PECAM-1 labelling antibody (4mg) were given intrascrotally at T¼ 0 h. A second
dose of C3 (1mg) was given intrascrotally and TRITC–dextran (40 kDa, 200ml/
40mM) was injected intravenously at T¼ 2 h and allowed to circulate until T¼ 4 h.
At T¼ 4 h animals were sacrificed and tissues were subjected to vascular wash out
by perfusion of 10 ml PBS via the left ventricle. Tissues were examined by confocal
microscopy (Leica SP5, 20 objective) and the level of TRITC–dextran
fluorescence by region of interest in the surrounding tissue was quantified using the
LAS-AF Lite software. Neutrophil extravasation per 5 104 mm2 tissue area was
quantified by endogenous GFP fluorescence in the neutrophils of LysM–GFP mice,
or by fixation and labelling of neutrophils with anti-MRP14-alexa647 in WT mice
after analysis of TRITC–dextran leakage in unfixed tissues. All in vivo experiments
followed UK legislation for the protection of animals and were approved by the
Ethical Review Process of Queen Mary, University of London.
F-actin visualization in retinal vasculature of Lifeact-GFP mice. Lifeact-EGFP
transgenic mice have been previously described26. All experiments with mice were
performed in accordance to German guidelines and regulations. Mice were
analysed at p7 and gender was randomly picked. The protocol was approved by the
Committee on the Ethics of Animal Experiments of the Ludwig-Maximilians
University Munich.
Whole-retina immunohistochemistry. Dissection and labelling of retinas was
performed as previously described27. Briefly, retinas were fixed for 2 h on ice in 4%
paraformaldehyde, incubated in 1% BSA and 0.3% Triton X-100, washed two times
in Pblec (1% Triton X-100, 1 mM CaCl2, 1 mM MgCl2, and 1 mM MnCl2 PBS
(pH 6.8)), and incubated overnight with isolectin-B4 (1:50) and antibodies diluted
in Pblec. Images were acquired and processed using a Leica TCS SP5 II microscope,
LAS Montage Imaging software (Leica) and the IMARIS Digital Imaging software
(Biplane). Biotinylated Griffonia simplicifolia lectin I (IB4), (B-1205) was purchased
from Vector Laboratories.
Western blotting. Cells were washed twice with PBS, and lysed with 95 C
SDS-sample buffer containing 4% b-mecapto-ethanol. Samples were boiled at
95 C for 4 min to denature proteins. Proteins were separated on 4–12% NuPAGE
Novex Bis-Tris gels (Invitrogen), transferred to Immobilon-PVDF transfer
membranes (Millipore Corp., Billerica, MA) and subsequently blocked with 2.5%
(w/v) BSA in Tris-buffered saline with Tween 20 for 60 min. The immunoblots
were analysed using primary antibodies incubated overnight at 4 C and secondary
antibodies linked to horseradish peroxidase (HRP) (GE Healthcare, UK), after each
step immunoblots were washed 6 with Tris-buffered saline with Tween 20.
Signals were visualized by enhanced chemiluminescence and light sensitive films
(GE Healthcare, UK). The full blots of all immunoblots presented in the study are
shown in Supplementary Fig. 8.
Pull-out assay and immunoprecipitation. Volume of 1.2 mg ml 1 dynabeads
goat-x-ms IgG (Dynal, Invitrogen) per condition were washed ones with 1 ml
buffer 1 containing PBSþ 2 mM EDTA and 0.1% BSA (Millipore) using a magnetic
holder. Dynabeads were coated with 1.6 mg a-ICAM-1 CD54 (BBIG-I1/IIC81, R&D
systems (Cat #BBA9) antibodies per condition and incubated head-over-head at
4 C for 45 min. The beads were washed twice using buffer 1 and resuspended in
PBS containing 0.5 MgCl2 and 1 mM CaCl2. Overnight TNF-a treated
(10 ng ml 1) HUVEC (2–5 million cells) were pretreated with 1 mM Ionomycin
(Invitrogen, I-24222) for 10 min. 1.2 mg ml 1 dynabeads per condition were used
to cluster ICAM-1 for 10–30 min. Cells were washed once on ice using PBS con-
taining 0.5 MgCl2 and 1 mM CaCl2. Next, cells were lysed in 1 ml cold pH7.4 RIPA
buffer containing 50 mM Tris, 100 mM NaCl, 10 mM MgCl2, 1% NP40, 10% gly-
cerol, 0.1% SDS, 1% DOC (Sigma-Aldrich), DNAse inhibitor and protease phos-
phatase inhibitor cocktail for 5 min. Cells were scraped together and lysates were
transferred to a new tube. Then, ICAM-1 coated dynabeads were added to non-
clustered-control cells. 50 ml whole-cell lysate was taken from all conditions. Beads
and cell-lysates were subsequently incubated head-over-head for 1–2 h at 4 C.
Next cells were washed twice with Ripa buffer and three times with NP-40 lysis
buffer. Beads were resuspended in 30 ml 2 SDS-sample buffer and assessed by
western blotting.
Electric cell–substrate impedance sensing under flow. Endothelial monolayer
integrity during leukocyte diapedesis was determined by measuring the electrical
resistance using Electric Cell–substrate Impedance Sensing (ECIS). Flow chamber
electrode arrays (8F10E; Applied Biophysics, Troy, NY) were pretreated with
10 mM L-cysteine (Sigma-Aldrich) for 15 min at 37 C, subsequently washed twice
with 0.9% NaCl and coated with FN (Sanquin) in 0.9% NaCl for 1 h at 37 C. Cells
were seeded at 300,000 cells per slide (2.5 cm2) and grown to confluence.
Continuous resistance measurements were performed at 37 C at 5% CO2 with the
ECIS ZY (Theta) system controller (Applied Biophysics). After forming a stable
monolayer, HUVECs were subjected to flow (0.8 dynes per cm2) for periods as
indicated.
Statistics. Endothelial pore analyses between leukocyte subtypes was tested using
a one-way analysis of variance assuming no matching or pairing, comparing the
mean of each column with the mean of every other column, that were corrected for
multiple comparisons by Tukey’s multiple comparisons test, with a single pooled
variance. Statistical comparison between experimental groups was performed by
the Student’s T-test. A two-tailed P value of o0.05 was considered significant.
Correlation analysis of dextran and neutrophil extravasation kinetics was
performed by Pearson’s correlation. Unless otherwise stated, a representative
experiment out of at least three independent experiments is shown.
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